Accurate Group Releases 2023 U.S. Home Equity Loan and Homeowner Intent Survey
Accurate Group, a leading provider of technology-driven real estate appraisal, title data, analytics, and e-closing solutions, today released its 2023 U.S. Housing Equity Loan Survey. The survey was sent to 1,000 consumers across the nation in Q1 2023, designed to capture homeowner intentions and tolerance for engaging in real estate lending over the next 12 months ? with a specific focus on how homeowners plan to leverage home equity. Survey questions centered around the likelihood of homeowners to apply for a home equity line of credit or loan, refinance an existing mortgage or take out a reverse mortgage.
The survey results provide lenders, loan servicers and originators with critical insights into borrowers' plans to participate in the real estate lending market during this time of global economic uncertainty and high interest rates.
Key findings of Accurate Group's 2023 U.S. Home Equity Loan Survey include:
26% of homeowners are very likely or likely to borrow against their home equity in the next 12 months; 51% are unlikely or very unlikely to borrow against their home equity; 23% are neutral.
71% of homeowners plan to take out a home equity loan or line of credit (HELOC)
31% of homeowners plan to refinance a mortgage
7% of homeowners plan to take out a reverse mortgage
Top 3 reasons homeowners are taking out a HELOC
35% for home improvement
15% for a major purchase
13% to pay off high interest loans
Four biggest factors impacting a decision to borrow against equity
50% interest rate of the loan
40% amount of equity available to borrow against
35% performance of financial investments
41% job security
"Higher mortgage rates, record levels of home price appreciation, constrained housing inventories and economic inflation are challenging for both lenders and borrowers," said Paul Doman, president and CEO of Accurate Group. "We conducted this survey to give lenders, loan services and originators better insight into homeowner sentiment to help them plan appropriately and identify strategic opportunities for loan volume growth. This report sheds light on what lenders could expect in the next 12 months as they navigate the evolving real estate market."
For the full breakdown of key findings, contact Accurate Group for a copy of our 2023 Home Equity Survey Infographic.
About Accurate Group
Accurate Group is a real estate technology and services leader delivering technology-driven property appraisal, title data, analytics and digital closing solutions to banks, credit unions, servicers, non-banks, and capital market firms. By combining modern process automation, accurate data and innovative SaaS and mobile technologies, Accurate Group provides its clients with the best combination of speed, quality, regulatory compliance, and price. With Accurate Group, the real estate finance community and consumers benefit from market-leading solutions that enable modern digital frameworks, improve accuracy, lower costs, and improve compliance across all types of real estate loans, mortgage-related assets and real estate portfolios. Visit www.accurategroup.com.
Drug Farm announced today the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of DF-003, a first-in-class, oral, potent, highly selective alpha-kinase 1 (ALPK1) inhibitor for clinical evaluation in...
RLX Technology Inc. ("RLX Technology" or the "Company") , a leading global branded e-vapor company, today announced its unaudited financial results for the first quarter ended March 31, 2024.
First Quarter 2024 Financial Highlights
Net revenues were...
Blackview, a pioneering smart-device technology brand, announced today the global launch of its first flip smartphone, the Blackview HERO 10. To democratize expensive flip phones, it is positioned as the world's cheapest foldable phone yet with...
Canaan Inc. ("Canaan" or the "Company"), a leading high-performance computing solutions provider, today announced its unaudited financial results for the three months ended March 31, 2024.
First Quarter 2024 Operating and Financial Highlights...
'Companion Diagnostics: Technologies and Markets' is all about using special tests alongside certain medicines to figure out which treatment will work best for each person. These tests are called companion diagnostics because they go together with...
WellSync, an API-driven virtual care service provider, today announced its partnership with The Vitamin Shoppe to launch Whole Health Rx, a cutting-edge telehealth service providing access to GLP-1 medications for weight management. WellSync provides...